Amide proton transfer weighted contrast has diagnostic capacity in detecting diabetic foot: an MRI-based case –control study

ConclusionNormalized MTRasym (3.5 ppm) and the BF in lesion may be treated as a safer and more convenient new indicator to evaluate the tissue infection without using a contrast agent, which may be useful in monitoring and preoperatively assessing DF patients with renal insufficiency.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research